Dr. Blake Gilks is a Professor Emeritus in the Dept of Pathology and Laboratory Medicine, at the University of British Columbia, and does clinical service work in the Division of Anatomic Pathology at Vancouver General Hospital, the site of the largest gynecological oncology program in the province of British Columbia, where he is Regional Medical Director of Laboratories and past-Head of the Department of Pathology and Laboratory Medicine. He graduated from Dalhousie University medical school in 1982 and did a residency in anatomical pathology at the University of British Columbia, followed by fellowships in gynecological pathology and molecular pathology at Massachusett’s General Hospital and Fox Chase Cancer Center, respectively. 

He leads a research program focused on gynecological cancers. He was lead pathologist on studies refining the histotype- based classification of ovarian carcinoma, molecular classification of endometrial carcinoma, and etiology-based classification of vulvar carcinoma, and was part of the team that championed opportunistic salpingectomy to prevent tubo-ovarian high grade serous carcinoma. He has been an author on more than 450 peer-reviewed publications, with more than 40,000 citations. He is co-founder and medical-director of the Canadian Pathology Quality Assurance program, which provides proficiency testing for Canadian diagnostic immunohistochemistry laboratories. 

Dr. Gilks has been recognized with the 2019 Terry Fox Medal and has served as the president of the International Society of Gynecologic Pathology. He is co-founder of OVCARE, BC’s gynecologic cancer research program. 


PubMed ID